Insider Trading & Ownership of BIOTECHNOLOGY VALUE FUND L P

Location
San Francisco, CA
Summary
The estimated value of insider holdings of BIOTECHNOLOGY VALUE FUND L P is at least $17,648,649 dollars as of 02 Apr 2026. BIOTECHNOLOGY VALUE FUND L P is the Director, 10%+ Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $17.65M.
Signature
Mark N. Lampert
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow BIOTECHNOLOGY VALUE FUND L P and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • BIOTECHNOLOGY VALUE FUND L P has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $17,648,649.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: MoonLake Immunotherapeutics ($17,648,649).
  • Past-year value change for that position: -$62,962,500.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of BIOTECHNOLOGY VALUE FUND L P

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MLTX MoonLake Immunotherapeutics Director, 10%+ Owner $17,648,649 -$62,962,500 -78% 31 Mar 2026

Insider Transactions Reported by BIOTECHNOLOGY VALUE FUND L P:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored